Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 36 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
351 20.2 months Castration-resistant prostate cancer 5 Chemotherapy
Hormone
Memorial Sloan-Kettering Cancer Center United States 6/2011
Treatment Details: Patients: This phase III study involved men with castration-resistant prostate cancer. Patients were divided into two treatment groups. Group A consisted of 476 patients with a median age
 
352 20.1 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
Hellenic Oncology Research Group Greece 4/2014
Treatment Details: Patients: This phase 2 study involved 48 elderly metastatic colorectal cancer patients who had not been previously treated. The median patient age was 76 years (range of 70-86) years and 5
 
353 20.1 months Hepatocellular Carcinoma 5 Biologic therapy
Chemotherapy
Heinrich-Heine-University Düsseldorf Germany 11/2014
Treatment Details: Patients: This phase 2 study involved 43 untreated hepatocellular carcinoma patients with an average age of 69 years; 86% were male. Treatment: Patients received chemotherapy with trans
 
354 20.0 months GBM 4 Chemotherapy
Radiation
Kizawa Memorial Hospital Japan 5/2014
Treatment Details: Patients: This study involved 45 glioblastoma multiforme patients. The median patient age was 61 years and 62.2% were male. Treatment: Patients were treated with hypofractionated, high
 
355 20.0 months Castration-resistant prostate cancer 4 Biologic therapy
The University of Chicago Comprehensive Cancer Centre United States 2/2014
Treatment Details: Patients: This phase 2 study involved 32 chemotherapy-naïve castration-resistant prostate cancer patients with an average age of 74 years. Treatment: Patients were treated with the biol
 
356 20.0 months GBM 5 Chemotherapy
Radiation
Chiba Cancer Center Japan 3/2014
Treatment Details: Patients: This phase 2 study involved 46 glioblastoma multiforme patients with a median age of 65.5 years; 30 were male. Treatment: Patients were treated with radiation therapy and the
 
357 20.0 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
University of Ulsan College of Medicine Korea 2/2014
Treatment Details: Patients: This phase 2 study involved 49 metastatic colorectal cancer patients who were not previously treated. The median patient age was 57 years and 30 were male. Treatment: Patient
 
358 20.0 months Metastatic, castration-resistant prostate cancer 5 Biologic therapy
Chemotherapy
Institut Gustave Roussy, University of Paris Sud France 4/2013
Treatment Details: Patients: This phase 3 study involved metastatic castration-resistant prostate cancer patients who were divided into two separate treatment groups. Group A consisted of 524 male patients w
 
359 20.0 months Unresectable colorectal cancer metastases 5 Surgery
Saint John's Health Center United States 3/2002
Treatment Details: Patients: This Phase II study involved 185 patients with unresectable colorectal hepatic (liver) metastases that had gotten worse (i.e. progressed by CT and/or CEA levels) while these patie
 
360 20.0 months Unresectable colorectal cancer metastases 5 Surgery
Saint John's Health Center United States 3/2002
Treatment Details: Patients: This Phase II study involved 185 patients with unresectable colorectal hepatic (liver) metastases that had become worse (i.e. progressed by CT and/or CEA levels) while these patie
 
Page 36 of 187  | Previous Page  | Next Page